{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:44:46Z","timestamp":1791265486104,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2011,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The attenuated Yellow fever (YF) 17D vaccine virus is one of the safest and most effective viral vaccines administered to humans, in which it elicits a polyvalent immune response. Herein, we used the YF 17D backbone to express a<jats:italic>Trypanosoma cruzi<\/jats:italic>CD8<jats:sup>+<\/jats:sup>T cell epitope from the Amastigote Surface Protein 2 (ASP-2) to provide further evidence for the potential of this virus to express foreign epitopes. The TEWETGQI CD8<jats:sup>+<\/jats:sup>T cell epitope was cloned and expressed based on two different genomic insertion sites: in the<jats:italic>fg<\/jats:italic>loop of the viral Envelope protein and the protease cleavage site between the NS2B and NS3. We investigated whether the site of expression had any influence on immunogenicity of this model epitope.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Recombinant viruses replicated similarly to vaccine virus YF 17D in cell culture and remained genetically stable after several serial passages in Vero cells. Immunogenicity studies revealed that both recombinant viruses elicited neutralizing antibodies to the YF virus as well as generated an antigen-specific gamma interferon mediated T-cell response in immunized mice. The recombinant viruses displayed a more attenuated phenotype than the YF 17DD vaccine counterpart in mice. Vaccination of a mouse lineage highly susceptible to infection by<jats:italic>T. cruzi<\/jats:italic>with a homologous prime-boost regimen of recombinant YF viruses elicited TEWETGQI specific CD8<jats:sup>+<\/jats:sup>T cells which might be correlated with a delay in mouse mortality after a challenge with a lethal dose of<jats:italic>T. cruzi<\/jats:italic>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We conclude that the YF 17D platform is useful to express<jats:italic>T. cruzi<\/jats:italic>(Protozoan) antigens at different functional regions of its genome with minimal reduction of vector fitness. In addition, the model<jats:italic>T. cruzi<\/jats:italic>epitope expressed at different regions of the YF 17D genome elicited a similar T cell-based immune response, suggesting that both expression sites are useful. However, the epitope as such is not protective and it remains to be seen whether expression of larger domains of ASP-2, which include the TEWETGQI epitope, will elicit better T-CD8+ responses to the latter. It is likely that additional antigens and recombinant virus formulations will be necessary to generate a protective response.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-8-127","type":"journal-article","created":{"date-parts":[[2011,3,18]],"date-time":"2011-03-18T19:15:45Z","timestamp":1300475745000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Biological and immunological characterization of recombinant Yellow Fever 17D Viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+T cell epitope at two distinct regions of the genome"],"prefix":"10.1186","volume":"8","author":[{"given":"Raquel T","family":"Nogueira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanderson R","family":"Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian CS","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio M","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myrna C","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,18]]},"reference":[{"key":"1239_CR1","first-page":"1101","volume-title":"Fields Virology","author":"B Lindenbach","year":"2007","unstructured":"Lindenbach B, Thiel HJ, Rice CM: Flaviviridae: the viruses and their replication. Fields Virology. Edited by: Knipe DM HP, Griffin DE, Martin MA, Lamb RA, Roizman B, Straus SE. 2007, Philadelphia: Wolters Kluwer, Lippincott Williams and Wilkins, 1101-1152. 5","edition":"5"},{"key":"1239_CR2","first-page":"1095","volume-title":"Vaccines","author":"T Monath","year":"2004","unstructured":"Monath T: Yellow fever vaccine. Vaccines. Edited by: Plotkin SAO W. 2004, Philadelphia: WB Saunders, 1095-1176. 4","edition":"4"},{"key":"1239_CR3","first-page":"895","volume":"59","author":"J Poland","year":"1981","unstructured":"Poland J, Calisher C, Monath T, Downs W, Murphy K: Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bull World Health Organ. 1981, 59: 895-900.","journal-title":"Bull World Health Organ"},{"key":"1239_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","volume":"56","author":"B Reinhardt","year":"1998","unstructured":"Reinhardt B, Jaspert R, Niedrig M, Kostner C, L'age-Stehr J: Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection. J Med Virol. 1998, 56: 159-167. 10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B.","journal-title":"J Med Virol"},{"key":"1239_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.2001.1255","volume":"293","author":"M Co","year":"2002","unstructured":"Co M, Terajima M, Cruz J, Ennis F, Rothman A: Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E. Virology. 2002, 293: 151-163. 10.1006\/viro.2001.1255.","journal-title":"Virology"},{"key":"1239_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","volume":"28","author":"J Miller","year":"2008","unstructured":"Miller J, van der Most R, Akondy R, Glidewell J, Albott S, Masopust D, Murali-Krishna K, Mahar P, Edupuganti S, Lalor S, et al: Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity. 2008, 28: 710-722. 10.1016\/j.immuni.2008.02.020.","journal-title":"Immunity"},{"key":"1239_CR7","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","volume":"183","author":"R Akondy","year":"2009","unstructured":"Akondy R, Monson N, Miller J, Edupuganti S, Teuwen D, Wu H, Quyyumi F, Garg S, Altman J, Del Rio C, et al: The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response. J Immunol. 2009, 183: 7919-7930. 10.4049\/jimmunol.0803903.","journal-title":"J Immunol"},{"key":"1239_CR8","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1084\/jem.20051720","volume":"203","author":"T Querec","year":"2006","unstructured":"Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B: Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med. 2006, 203: 413-424. 10.1084\/jem.20051720.","journal-title":"J Exp Med"},{"key":"1239_CR9","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1084\/jem.20082292","volume":"205","author":"D Gaucher","year":"2008","unstructured":"Gaucher D, Therrien R, Kettaf N, Angermann B, Boucher G, Filali-Mouhim A, Moser J, Mehta R, Drake Dr, Castro E, et al: Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med. 2008, 205: 3119-3131. 10.1084\/jem.20082292.","journal-title":"J Exp Med"},{"key":"1239_CR10","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/ni.1688","volume":"10","author":"T Querec","year":"2009","unstructured":"Querec T, Akondy R, Lee E, Cao W, Nakaya H, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, et al: Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2009, 10: 116-125. 10.1038\/ni.1688.","journal-title":"Nat Immunol"},{"key":"1239_CR11","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","volume":"28","author":"B Guy","year":"2010","unstructured":"Guy B, Guirakhoo F, Barban V, Higgs S, Monath T, Lang J: Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses. Vaccine. 2010, 28: 632-649. 10.1016\/j.vaccine.2009.09.098.","journal-title":"Vaccine"},{"key":"1239_CR12","doi-asserted-by":"publisher","first-page":"9197","DOI":"10.1128\/JVI.74.19.9197-9205.2000","volume":"74","author":"A McAllister","year":"2000","unstructured":"McAllister A, Arbetman A, Mandl S, Pe\u00f1a-Rossi C, Andino R: Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases. J Virol. 2000, 74: 9197-9205. 10.1128\/JVI.74.19.9197-9205.2000.","journal-title":"J Virol"},{"key":"1239_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1084\/jem.20041526","volume":"201","author":"D Tao","year":"2005","unstructured":"Tao D, Barba-Spaeth G, Rai U, Nussenzweig V, Rice C, Nussenzweig R: Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model. J Exp Med. 2005, 201: 201-209. 10.1084\/jem.20041526.","journal-title":"J Exp Med"},{"key":"1239_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","volume":"315","author":"M Bonaldo","year":"2002","unstructured":"Bonaldo M, Garratt R, Caufour P, Freire M, Rodrigues M, Nussenzweig R, Galler R: Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J Mol Biol. 2002, 315: 873-885. 10.1006\/jmbi.2001.5258.","journal-title":"J Mol Biol"},{"key":"1239_CR15","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1385\/CBB:44:3:313","volume":"44","author":"M Bonaldo","year":"2006","unstructured":"Bonaldo M, Garratt R, Freire M, Galler R: Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein. Cell Biochem Biophys. 2006, 44: 313-324. 10.1385\/CBB:44:3:313.","journal-title":"Cell Biochem Biophys"},{"key":"1239_CR16","doi-asserted-by":"publisher","first-page":"8602","DOI":"10.1128\/JVI.79.13.8602-8613.2005","volume":"79","author":"M Bonaldo","year":"2005","unstructured":"Bonaldo M, Garratt R, Marchevsky R, Coutinho E, Jabor A, Almeida L, Yamamura A, Duarte A, Oliveira P, Lizeu J, et al: Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface. J Virol. 2005, 79: 8602-8613. 10.1128\/JVI.79.13.8602-8613.2005.","journal-title":"J Virol"},{"key":"1239_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.virol.2008.04.043","volume":"378","author":"MJ Maciel","year":"2008","unstructured":"Maciel MJ, Kellathur S, Chikhlikar P, Dhalia R, Sidney J, Sette A, August T, Marques EJ: Comprehensive analysis of T cell epitope discovery strategies using 17DD yellow fever virus structural proteins and BALB\/c (H2d) mice model. Virology. 2008, 378: 105-117. 10.1016\/j.virol.2008.04.043.","journal-title":"Virology"},{"key":"1239_CR18","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00251-010-0461-0","volume":"62","author":"P Mudd","year":"2010","unstructured":"Mudd P, Piaskowski S, Neves P, Rudersdorf R, Kolar H, Eernisse C, Weisgrau K, de Santana M, Wilson N, Bonaldo M, et al: The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design. Immunogenetics. 2010, 62: 593-600. 10.1007\/s00251-010-0461-0.","journal-title":"Immunogenetics"},{"key":"1239_CR19","volume-title":"Book Tropical Disease Research: progress 2003-2004 (Editor ed.^eds.). City","author":"WHO","year":"2005","unstructured":"WHO: Tropical Disease Research: progress 2003-2004. Book Tropical Disease Research: progress 2003-2004 (Editor ed.^eds.). City. 2005"},{"key":"1239_CR20","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1086\/651608","volume":"201","author":"B Alarc\u00f3n de Noya","year":"2010","unstructured":"Alarc\u00f3n de Noya B, D\u00edaz-Bello Z, Colmenares C, Ruiz-Guevara R, Mauriello L, Zavala-Jaspe R, Suarez J, Abate T, Naranjo L, Paiva M, et al: Large urban outbreak of orally acquired acute Chagas disease at a school in Caracas, Venezuela. J Infect Dis. 2010, 201: 1308-1315.","journal-title":"J Infect Dis"},{"key":"1239_CR21","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4049\/jimmunol.160.4.1817","volume":"160","author":"H Low","year":"1998","unstructured":"Low H, Santos M, Wizel B, Tarleton R: Amastigote surface proteins of Trypanosoma cruzi are targets for CD8+ CTL. J Immunol. 1998, 160: 1817-1823.","journal-title":"J Immunol"},{"key":"1239_CR22","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1172\/JCI3835","volume":"102","author":"B Wizel","year":"1998","unstructured":"Wizel B, Palmieri M, Mendoza C, Arana B, Sidney J, Sette A, Tarleton R: Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J Clin Invest. 1998, 102: 1062-1071. 10.1172\/JCI3835.","journal-title":"J Clin Invest"},{"key":"1239_CR23","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1128\/IAI.70.10.5547-5555.2002","volume":"70","author":"N Garg","year":"2002","unstructured":"Garg N, Tarleton R: Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect Immun. 2002, 70: 5547-5555. 10.1128\/IAI.70.10.5547-5555.2002.","journal-title":"Infect Immun"},{"key":"1239_CR24","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1128\/IAI.71.5.2744-2757.2003","volume":"71","author":"S Boscardin","year":"2003","unstructured":"Boscardin S, Kinoshita S, Fujimura A, Rodrigues M: Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection. Infect Immun. 2003, 71: 2744-2757. 10.1128\/IAI.71.5.2744-2757.2003.","journal-title":"Infect Immun"},{"key":"1239_CR25","doi-asserted-by":"publisher","first-page":"6017","DOI":"10.1128\/IAI.73.9.6017-6025.2005","volume":"73","author":"A Ara\u00fajo","year":"2005","unstructured":"Ara\u00fajo A, de Alencar B, Vasconcelos J, Hiyane M, Marinho C, Penido M, Boscardin S, Hoft D, Gazzinelli R, Rodrigues M: CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect Immun. 2005, 73: 6017-6025.","journal-title":"Infect Immun"},{"key":"1239_CR26","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1016\/j.vaccine.2007.05.022","volume":"25","author":"BC de Alencar","year":"2007","unstructured":"de Alencar BC, Araujo AF, Penido ML, Gazzinelli RT, Rodrigues MM: Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells. Vaccine. 2007, 25: 6018-6027. 10.1016\/j.vaccine.2007.05.022.","journal-title":"Vaccine"},{"key":"1239_CR27","first-page":"815","volume-title":"Vaccines","author":"T Monath","year":"1999","unstructured":"Monath T: Yellow fever. Vaccines. Edited by: Plotkin SA OW. 1999, USA: W.B. Saunders Company, 815-998. 3","edition":"3"},{"key":"1239_CR28","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1089\/hum.2004.15.878","volume":"15","author":"J Vasconcelos","year":"2004","unstructured":"Vasconcelos J, Hiyane M, Marinho C, Claser C, Machado A, Gazzinelli R, Bru\u00f1a-Romero O, Alvarez J, Boscardin S, Rodrigues M: Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase. Hum Gene Ther. 2004, 15: 878-886.","journal-title":"Hum Gene Ther"},{"key":"1239_CR29","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1128\/IAI.01163-07","volume":"76","author":"S Cazorla","year":"2008","unstructured":"Cazorla S, Becker P, Frank F, Ebensen T, Sartori M, Corral R, Malchiodi E, Guzm\u00e1n C: Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi. Infect Immun. 2008, 76: 324-333. 10.1128\/IAI.01163-07.","journal-title":"Infect Immun"},{"key":"1239_CR30","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1128\/IAI.01459-08","volume":"77","author":"B de Alencar","year":"2009","unstructured":"de Alencar B, Persechini P, Haolla F, de Oliveira G, Silverio J, Lannes-Vieira J, Machado A, Gazzinelli R, Bruna-Romero O, Rodrigues M: Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination. Infect Immun. 2009, 77: 4383-4395. 10.1128\/IAI.01459-08.","journal-title":"Infect Immun"},{"key":"1239_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.0818-9641.2002.01136.x","volume":"81","author":"J Vasconcelos","year":"2003","unstructured":"Vasconcelos J, Boscardin S, Hiyane M, Kinoshita S, Fujimura A, Rodrigues M: A DNA-priming protein-boosting regimen significantly improves type 1 immune response but not protective immunity to Trypanosoma cruzi infection in a highly susceptible mouse strain. Immunol Cell Biol. 2003, 81: 121-129. 10.1046\/j.0818-9641.2002.01136.x.","journal-title":"Immunol Cell Biol"},{"key":"1239_CR32","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1128\/JVI.02255-09","volume":"84","author":"M Bonaldo","year":"2010","unstructured":"Bonaldo M, Martins M, Rudersdorf R, Mudd P, Sacha J, Piaskowski S, Costa Neves P, Veloso de Santana M, Vojnov L, Capuano Sr, et al: Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques. J Virol. 2010, 84: 3699-3706. 10.1128\/JVI.02255-09.","journal-title":"J Virol"},{"key":"1239_CR33","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","volume":"28","author":"D Franco","year":"2010","unstructured":"Franco D, Li W, Qing F, Stoyanov C, Moran T, Rice C, Ho D: Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development. Vaccine. 2010, 28: 5676-5685. 10.1016\/j.vaccine.2010.06.052.","journal-title":"Vaccine"},{"key":"1239_CR34","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1016\/j.vaccine.2010.04.071","volume":"28","author":"C Stoyanov","year":"2010","unstructured":"Stoyanov C, Boscardin S, Deroubaix S, Barba-Spaeth G, Franco D, Nussenzweig R, Nussenzweig M, Rice C: Immunogenicity and protective efficacy of a recombinant yellow fever vaccine against the murine malarial parasite Plasmodium yoelii. Vaccine. 2010, 28: 4644-4652. 10.1016\/j.vaccine.2010.04.071.","journal-title":"Vaccine"},{"key":"1239_CR35","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1084\/jem.20051352","volume":"202","author":"G Barba-Spaeth","year":"2005","unstructured":"Barba-Spaeth G, Longman R, Albert M, Rice C: Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes. J Exp Med. 2005, 202: 1179-1184. 10.1084\/jem.20051352.","journal-title":"J Exp Med"},{"key":"1239_CR36","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.virol.2009.10.033","volume":"396","author":"A Rumyantsev","year":"2010","unstructured":"Rumyantsev A, Zhang Z, Gao Q, Moretti N, Brown N, Kleanthous H, Delagrave S, Guirakhoo F, Collett M, Pugachev K: Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus. Virology. 2010, 396: 329-338. 10.1016\/j.virol.2009.10.033.","journal-title":"Virology"},{"key":"1239_CR37","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1128\/CVI.00142-08","volume":"15","author":"E Silveira","year":"2008","unstructured":"Silveira E, Claser C, Haolla F, Zanella L, Rodrigues M: Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease. Clin Vaccine Immunol. 2008, 15: 1292-1300. 10.1128\/CVI.00142-08.","journal-title":"Clin Vaccine Immunol"},{"key":"1239_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.coi.2010.01.022","volume":"22","author":"S Amigorena","year":"2010","unstructured":"Amigorena S, Savina A: Intracellular mechanisms of antigen cross presentation in dendritic cells. Curr Opin Immunol. 2010, 22: 109-117. 10.1016\/j.coi.2010.01.022.","journal-title":"Curr Opin Immunol"},{"key":"1239_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/1743-422X-4-115","volume":"4","author":"M Bonaldo","year":"2007","unstructured":"Bonaldo M, Mello S, Trindade G, Rangel A, Duarte A, Oliveira P, Freire M, Kubelka C, Galler R: Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J. 2007, 4: 115-10.1186\/1743-422X-4-115.","journal-title":"Virol J"},{"key":"1239_CR40","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1371\/journal.pone.0000393","volume":"2","author":"F Tzelepis","year":"2007","unstructured":"Tzelepis F, Persechini P, Rodrigues M: Modulation of CD4(+) T cell-dependent specific cytotoxic CD8(+) T cells differentiation and proliferation by the timing of increase in the pathogen load. PLoS One. 2007, 2: e393-10.1371\/journal.pone.0000393.","journal-title":"PLoS One"},{"key":"1239_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1590\/S0001-37652003000400005","volume":"75","author":"M Rodrigues","year":"2003","unstructured":"Rodrigues M, Boscardin S, Vasconcelos J, Hiyane M, Salay G, Soares I: Importance of CD8 T cell-mediated immune response during intracellular parasitic infections and its implications for the development of effective vaccines. An Acad Bras Cienc. 2003, 75: 443-468.","journal-title":"An Acad Bras Cienc"},{"key":"1239_CR42","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.0105-2896.2004.00183.x","volume":"201","author":"D Martin","year":"2004","unstructured":"Martin D, Tarleton R: Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev. 2004, 201: 304-317. 10.1111\/j.0105-2896.2004.00183.x.","journal-title":"Immunol Rev"},{"key":"1239_CR43","doi-asserted-by":"publisher","first-page":"595","DOI":"10.7326\/0003-4819-108-4-595","volume":"108","author":"H Murray","year":"1988","unstructured":"Murray H: Interferon-gamma, the activated macrophage, and host defense against microbial challenge. Ann Intern Med. 1988, 108: 595-608.","journal-title":"Ann Intern Med"},{"key":"1239_CR44","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1128\/IAI.74.4.2477-2481.2006","volume":"74","author":"F Tzelepis","year":"2006","unstructured":"Tzelepis F, de Alencar B, Penido M, Gazzinelli R, Persechini P, Rodrigues M: Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect Immun. 2006, 74: 2477-2481. 10.1128\/IAI.74.4.2477-2481.2006.","journal-title":"Infect Immun"},{"key":"1239_CR45","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","volume":"16","author":"R Galler","year":"1998","unstructured":"Galler R, Post P, Santos C, Ferreira I: Genetic variability among yellow fever virus 17D substrains. Vaccine. 1998, 16: 1024-1028. 10.1016\/S0264-410X(97)00278-8.","journal-title":"Vaccine"},{"key":"1239_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biologicals.2005.09.005","volume":"34","author":"R Marchevsky","year":"2006","unstructured":"Marchevsky R, da Luz Leal M, Homma A, Coutinho E, Camacho L, Jabor A, Galler R, Freire M: Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102\/84 with an additional passage in chicken embryos. Biologicals. 2006, 34: 191-197. 10.1016\/j.biologicals.2005.09.005.","journal-title":"Biologicals"},{"key":"1239_CR47","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.micinf.2007.04.006","volume":"9","author":"C Claser","year":"2007","unstructured":"Claser C, Esp\u00edndola N, Sasso G, Vaz A, Boscardin S, Rodrigues M: Immunologically relevant strain polymorphism in the Amastigote Surface Protein 2 of Trypanosoma cruzi. Microbes Infect. 2007, 9: 1011-1019. 10.1016\/j.micinf.2007.04.006.","journal-title":"Microbes Infect"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-8-127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T09:09:22Z","timestamp":1712308162000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-8-127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,18]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1239"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-8-127","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,18]]},"assertion":[{"value":"3 November 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"127"}}